Diclofenac (Rheumatology)
Brand names: Voltarol, Diclomax, Dyloject
In rheumatology, diclofenac is a non-steroidal anti-inflammatory drug used to relieve pain and inflammation in arthritis and other musculoskeletal conditions, available orally and as a topical preparation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits cyclo-oxygenase enzymes, reducing prostaglandin synthesis and thereby decreasing pain, swelling and inflammation.
Prescribing in practice
- Carries a higher cardiovascular thrombotic risk than other non-selective NSAIDs and is contraindicated in established cardiovascular disease — use the lowest effective dose for the shortest time.
- Also causes gastrointestinal ulceration and renal impairment; consider gastroprotection and avoid in severe heart failure, peptic ulceration or significant renal disease.
- Topical use limits systemic exposure for localised joint pain; consult the SPC and apply MHRA contraindication advice.
Monitoring
Monitor blood pressure, renal function and for gastrointestinal symptoms, especially in older or higher-risk patients on oral therapy.
Counselling the patient
- Take oral doses with food and report black stools or indigestion.
- Use the lowest dose for the shortest period needed.
- Wash hands after applying the topical gel and avoid broken skin.
Evidence & guidelines
Analgesic and anti-inflammatory efficacy in arthritis is well established, with cardiovascular risk highlighted by MHRA review.
Reference: NICE NG193; CHM/MHRA review 2013; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022